trending Market Intelligence /marketintelligence/en/news-insights/trending/aZUqa3InFDJQ9b8QaTeEyQ2 content esgSubNav
In This List

Biostar Pharmaceuticals director resigns

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection

Video

S&P Capital IQ Pro | Powered by Advanced Visualization

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge


Biostar Pharmaceuticals director resigns

Leung King Fai resigned as an independent director of Biostar Pharmaceuticals Inc., effective Dec. 12.

King Fai resigned because his director's fee from Jan. 1, 2014, to present had not been paid.